Tapewire

Nasdaq · USD

EXOZ

EXOZYMES INC.

Export transactions ↓
Tapewire entity
1147
SEC CIK
0002010788
Parsed reports
32

Last 12 months

Inside the activity.

5 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202602
May 202600
Jun 202600
Jul 202600
Aug 202650
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 14, 2026 Filed Sep 17, 2026 21:27 UTC
Nawaz FouadVice President- Finance
GrantStock Option (right to buy) · Derivative 45,000 $0.00 Strike: $6.28 $0.00
Disclosure

SEC source: 0001493152-26-043174 · ownership.xml · derivative · entry 2

Nawaz Fouad · CIK 0002030838 · Vice President- Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2033-09-14

F1 · derivative.exercise_date: The option vests over a three (3) year period in twelve (12) equal quarterly installments of 3,750 shares at the end of each quarter of the calendar year, commencing with the first full calendar quarter following the date of grant. The first installment vests on 12/31/2026 and the final installment vests on 09/30/2029. The option expires on 09/14/2033.

Read SEC document
August 26, 2026 Filed Sep 2, 2026 23:33 UTC
Heltzen MichaelChief Executive Officer
PurchaseCommon Stock 250 $7.60 $1,900.00
Disclosure

SEC source: 0001493152-26-041290 · ownership.xml · nonDerivative · entry 3

Heltzen Michael · CIK 0002030840 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,453

Read SEC document
August 26, 2026 Filed Sep 2, 2026 23:33 UTC
Heltzen MichaelChief Executive Officer
PurchaseCommon Stock 251 $7.35 $1,844.85
Disclosure

SEC source: 0001493152-26-041290 · ownership.xml · nonDerivative · entry 2

Heltzen Michael · CIK 0002030840 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,704

Read SEC document
August 26, 2026 Filed Sep 2, 2026 23:33 UTC
Heltzen MichaelChief Executive Officer
PurchaseCommon Stock 4 $7.58 $30.32
Disclosure

SEC source: 0001493152-26-041290 · ownership.xml · nonDerivative · entry 1

Heltzen Michael · CIK 0002030840 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,708

Read SEC document
August 25, 2026 Filed Sep 2, 2026 23:33 UTC
Heltzen MichaelChief Executive Officer
PurchaseCommon Stock 100 $7.50 $750.00
Disclosure

SEC source: 0001493152-26-041290 · ownership.xml · nonDerivative · entry 5

Heltzen Michael · CIK 0002030840 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,953

Read SEC document
August 25, 2026 Filed Sep 2, 2026 23:33 UTC
Heltzen MichaelChief Executive Officer
PurchaseCommon Stock 250 $7.52 $1,880.00
Disclosure

SEC source: 0001493152-26-041290 · ownership.xml · nonDerivative · entry 4

Heltzen Michael · CIK 0002030840 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,203

Read SEC document
August 19, 2026 Filed Aug 25, 2026 22:57 UTC
Korman Tyler PazChief Scientific Officer
Exercise / conversionRestricted Stock Unit · Derivative 32,964 $0.00 $0.00
Disclosure

SEC source: 0001493152-26-040116 · ownership.xml · derivative · entry 2

Korman Tyler Paz · CIK 0002032745 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,140

Underlying: Common Stock · 32,964 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The RSU convert on a one-for-one basis.

F2 · derivative.exercise_date: On March 28, 2022, and May 1, 2023, the reporting person was granted an aggregate of 79,104 RSUs, vesting periodically. The first vesting was August 19, 2026, in the amount of 32,964 shares of common stock.

F2 · derivative.expiration_date: On March 28, 2022, and May 1, 2023, the reporting person was granted an aggregate of 79,104 RSUs, vesting periodically. The first vesting was August 19, 2026, in the amount of 32,964 shares of common stock.

Read SEC document
August 19, 2026 Filed Aug 25, 2026 22:57 UTC
Korman Tyler PazChief Scientific Officer
Exercise / conversionCommon Stock 32,964 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-26-040116 · ownership.xml · nonDerivative · entry 1

Korman Tyler Paz · CIK 0002032745 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 762,837

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The RSU convert on a one-for-one basis.

Read SEC document
August 19, 2026 Filed Aug 25, 2026 23:16 UTC
Perriman Damien AlanChief Commercial Officer
Exercise / conversionRestricted Stock Unit · Derivative 19,612 $0.00 $0.00
Disclosure

SEC source: 0001493152-26-040129 · ownership.xml · derivative · entry 2

Perriman Damien Alan · CIK 0002096714 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,147

Underlying: Common Stock · 19,612 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The RSU convert on a one-for-one basis.

F2 · derivative.exercise_date: On January 14, 2026, the reporting person was granted an aggregate of 62,759 RSUs, vesting periodically. The first vesting was August 19, 2026, in the amount of 19,612 shares of common stock.

F2 · derivative.expiration_date: On January 14, 2026, the reporting person was granted an aggregate of 62,759 RSUs, vesting periodically. The first vesting was August 19, 2026, in the amount of 19,612 shares of common stock.

Read SEC document
August 19, 2026 Filed Aug 25, 2026 23:16 UTC
Perriman Damien AlanChief Commercial Officer
Exercise / conversionCommon Stock 19,612 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-26-040129 · ownership.xml · nonDerivative · entry 1

Perriman Damien Alan · CIK 0002096714 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,499

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The RSU convert on a one-for-one basis.

Read SEC document
August 19, 2026 Filed Sep 2, 2026 23:33 UTC
Heltzen MichaelChief Executive Officer
GrantCommon Stock 8,841 $6.40 $56,582.40
Disclosure

SEC source: 0001493152-26-041290 · ownership.xml · nonDerivative · entry 6

Heltzen Michael · CIK 0002030840 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,853

Read SEC document
April 09, 2026 Filed Apr 10, 2026 20:30 UTC
Korman Tyler PazChief Scientific Officer
SaleCOMMON STOCK 750 $10.53 $7,893.75
Disclosure

SEC source: 0001493152-26-016166 · ownership.xml · nonDerivative · entry 2

Korman Tyler Paz · CIK 0002032745 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 729,123

Read SEC document
April 08, 2026 Filed Apr 10, 2026 20:30 UTC
Korman Tyler PazChief Scientific Officer
SaleCOMMON STOCK 750 $10.04 $7,530.45
Disclosure

SEC source: 0001493152-26-016166 · ownership.xml · nonDerivative · entry 1

Korman Tyler Paz · CIK 0002032745 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 729,873

Read SEC document
April 01, 2026 Filed Apr 8, 2026 10:23 UTC
Opgenorth Paul HideoVice President, Development
GrantCOMMON STOCK 3,999 $8.44 $33,751.56
Disclosure

SEC source: 0001493152-26-015627 · ownership.xml · nonDerivative · entry 1

Opgenorth Paul Hideo · CIK 0002033517 · Vice President, Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 645,149

Read SEC document
April 01, 2026 Filed Apr 8, 2026 10:14 UTC
Korman Tyler PazChief Scientific Officer
GrantCOMMON STOCK 5,332 $8.44 $45,002.08
Disclosure

SEC source: 0001493152-26-015619 · ownership.xml · nonDerivative · entry 1

Korman Tyler Paz · CIK 0002032745 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 730,623

Read SEC document
April 01, 2026 Filed Apr 8, 2026 10:17 UTC
Nawaz FouadVice President- Finance
GrantCOMMON STOCK 5,999 $8.44 $50,631.56
Disclosure

SEC source: 0001493152-26-015622 · ownership.xml · nonDerivative · entry 1

Nawaz Fouad · CIK 0002030838 · Vice President- Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,488

Read SEC document
April 01, 2026 Filed Apr 8, 2026 23:22 UTC
Perriman Damien AlanChief Commercial Officer
GrantStock Option for Common Stock · Derivative 146,437 $0.00 Strike: $9.49 $0.00
Disclosure

SEC source: 0001493152-26-015761 · ownership.xml · derivative · entry 2

Perriman Damien Alan · CIK 0002096714 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 146,437

Underlying: Common Stock · 146,437 shares

Expires 2033-04-12

F2 · security: The shares underlying the stock option grant vest at a rate of 3,050 shares per month, with 36,609 shares vesting immediately. The final vesting installment consists of 3,078 shares on April 1, 2029. The grant and each exercise of the option is pursuant to Rule 16b-3 of Section 16 of the Securities and Exchange Act of 1934, as amended.

Read SEC document
April 01, 2026 Filed Apr 8, 2026 23:22 UTC
Perriman Damien AlanChief Commercial Officer
GrantRestricted Stock Grant for Common Stock 62,759 $0.00 $0.00
Disclosure

SEC source: 0001493152-26-015761 · ownership.xml · nonDerivative · entry 1

Perriman Damien Alan · CIK 0002096714 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,759

F1 · security: The shares underlying the grant of the restricted stock vest at a rate of 3,923 shares per quarter, with 15,689 shares vesting immediately. The final vesting installment consists of 3,917 shares on April 1, 2029. The grant and each vesting is pursuant to Rule 16b-3 of Section 16 of the Securities and Exchange Act of 1934, as amended.

Read SEC document
April 01, 2026 Filed Apr 8, 2026 10:27 UTC
Perriman Damien AlanChief Commercial Officer
GrantCOMMON STOCK 8,887 $8.44 $75,006.28
Disclosure

SEC source: 0001493152-26-015630 · ownership.xml · nonDerivative · entry 1

Perriman Damien Alan · CIK 0002096714 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Read SEC document
July 02, 2025 Filed Jul 2, 2025 17:49 UTC
Heltzen MichaelChief Executive Officer
PurchaseCommon Stock 1,040 $10.22 $10,628.80
Disclosure

SEC source: 0001641172-25-017630 · ownership.xml · nonDerivative · entry 1

Heltzen Michael · CIK 0002030840 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,628.8

Read SEC document
June 17, 2025 Filed Jun 20, 2025 12:31 UTC
Heltzen MichaelChief Executive Officer
GrantStock Options for Common Stock · Derivative 235,817 $0.00 Strike: $12.40 $0.00
Disclosure

SEC source: 0001641172-25-015778 · ownership.xml · derivative · entry 1

Heltzen Michael · CIK 0002030840 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 235,817

Underlying: Common Stock · 235,817 shares

Expires 2032-06-29

F1 · security: The Options will vest over a four (4) year period, in equal quarterly installments at the end of each quarter of the calendar year, and the Options will commence vesting on July 1, 2025.The option expires June 29, 2032.

Read SEC document
June 16, 2025 Filed Jun 17, 2025 21:22 UTC
Korman Tyler PazVice President, Research
GrantCommon Stock 2,990 $12.54 $37,494.60
Disclosure

SEC source: 0001641172-25-015460 · ownership.xml · nonDerivative · entry 1

Korman Tyler Paz · CIK 0002032745 · Vice President, Research

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 725,291

Read SEC document
June 13, 2025 Filed Jun 17, 2025 21:19 UTC
Opgenorth Paul HideoVice President, Development
GrantCommon Stock 2,990 $12.54 $37,494.60
Disclosure

SEC source: 0001641172-25-015458 · ownership.xml · nonDerivative · entry 1

Opgenorth Paul Hideo · CIK 0002033517 · Vice President, Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 641,150

Read SEC document
June 13, 2025 Filed Jun 17, 2025 21:09 UTC
Nawaz FouadVice President, Finance
GrantCommon Stock 3,489 $12.54 $43,752.06
Disclosure

SEC source: 0001641172-25-015456 · ownership.xml · nonDerivative · entry 1

Nawaz Fouad · CIK 0002030838 · Vice President, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,489

Read SEC document
January 17, 2025 Filed Jan 21, 2025 06:02 UTC
Heltzen MichaelChief Executive Officer
PurchaseCommon Stock 1,767 $10.78 $19,048.26
Disclosure

SEC source: 0001493152-25-002875 · ownership.xml · nonDerivative · entry 2

Heltzen Michael · CIK 0002030840 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,872

F1 · price: The reported price in Column 4 is a weighted average purchase price. The shares acquired on January 17, 2025 were purchased in multiple transactions at prices ranging from $10.45 to $11.00 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
January 16, 2025 Filed Jan 21, 2025 06:02 UTC
Heltzen MichaelChief Executive Officer
PurchaseCommon Stock 121 $10.72 $1,297.12
Disclosure

SEC source: 0001493152-25-002875 · ownership.xml · nonDerivative · entry 1

Heltzen Michael · CIK 0002030840 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,105

Read SEC document
November 15, 2024 Filed Nov 19, 2024 18:45 UTC
Heltzen MichaelChief Executive Officer
PurchaseCommon Stock 1,984 $11.10 $22,022.40
Disclosure

SEC source: 0001493152-24-046902 · ownership.xml · nonDerivative · entry 1

Heltzen Michael · CIK 0002030840 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,984

Read SEC document
November 08, 2024 Filed Nov 19, 2024 00:54 UTC
Opgenorth Paul HideoVice President, Development
ConversionCommon Stock 2,344 $6.40 $15,001.60
Disclosure

SEC source: 0001493152-24-046629 · ownership.xml · nonDerivative · entry 1

Opgenorth Paul Hideo · CIK 0002033517 · Vice President, Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 640,504

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 08, 2024 Filed Nov 19, 2024 00:53 UTC ConversionCommon Stock 122,657 $6.40 $785,004.80
Disclosure

SEC source: 0001493152-24-046627 · ownership.xml · nonDerivative · entry 1

MDB Capital Holdings, LLC · CIK 0001934642 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,931,133

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.